SCHEMBL25567697

SCHEMBL25567697

CC(C)(C(=O)O)C(=O)Nc1cc(C(C)(C)C)on1

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
EGFR P00533 1/20 0.59
NPC1 O15118 6/20 0.58
RAB9A P51151 6/20 0.58
MEN1 O00255 2/20 0.58
KMT2A Q03164 2/20 0.58
MAPK14 Q16539 3/20 0.54
SMN1; SMN2 Q16637 4/20 0.53
CNR1 P21554 2/20 0.53
CNR2 P34972 2/20 0.53
HPGD P15428 1/20 0.52
LMNA P02545 1/20 0.52
POLB P06746 1/20 0.52
HTT P42858 3/20 0.51
FLT3 P36888 2/20 0.51
PKM P14618 1/20 0.51
TSHR P16473 1/20 0.51
TDP1 Q9NUW8 1/20 0.51
MAPT P10636 2/20 0.50
MAPK13 O15264 1/20 0.50
RAF1 P04049 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16026822 0.86 EGFR (0.57) EGFRNPC1RAB9AMEN1KMT2A
SCHEMBL9891521 0.85 EGFR (0.64) EGFRNPC1RAB9AMEN1KMT2A
SCHEMBL25567678 0.84 EGFR (0.56) EGFRNPC1RAB9AMEN1KMT2A
SCHEMBL1464298 0.83 EGFR (0.62) EGFRNPC1RAB9AMEN1KMT2A
SCHEMBL12102149 0.83 EGFR (0.62) EGFRNPC1RAB9AMEN1KMT2A
SCHEMBL1758718 0.83 EGFR (0.66) EGFRNPC1RAB9AMEN1KMT2A
SCHEMBL14960393 0.82 EGFR (0.60) EGFRNPC1RAB9AMEN1KMT2A
SCHEMBL2951112 0.81 RAB9A (0.77) EGFRNPC1RAB9AMEN1KMT2A
SCHEMBL12376186 0.81 EGFR (0.59) EGFRNPC1RAB9AMEN1KMT2A
SCHEMBL4112548 0.80 EGFR (0.66) EGFRNPC1RAB9AMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023078207-A1 6-POSITION-SUBSTITUTED INDOLINONE DERIVATIVE, PREPARATION METHOD THEREFOR, AND MEDICAL USE THEREOF 南京中医药大学 2023-05-11 WO disclosed